Literature DB >> 25712926

In vitro passage selects for Chlamydia muridarum with enhanced infectivity in cultured cells but attenuated pathogenicity in mouse upper genital tract.

Chaoqun Chen1, Zhou Zhou1, Turner Conrad2, Zhangsheng Yang2, Jin Dai2, Zhongyu Li3, Yimou Wu4, Guangming Zhong5.   

Abstract

Although modern Chlamydia muridarum has been passaged for decades, there are no reports on the consequences of serial passage with strong selection pressure on its fitness. In order to explore the potential for Pasteurian selection to induce genomic and phenotypic perturbations to C. muridarum, a starter population was passaged in cultured cells for 28 generations without standard infection assistance. The resultant population, designated CMG28, displays markedly reduced in vitro dependence on centrifugation for infection and low incidence and severity of upper genital tract pathology following intravaginal inoculation into mice compared to the parental C. muridarum population, CMG0. Deep sequencing of CMG0 and CMG28 revealed novel protein variants in the hypothetical genes TC0237 (Q117E) and TC0668 (G322R). In vitro attachment assays of isogenic plaque clone pairs with mutations in either TC0237 and TC0668 or only TC0237 reveal that TC0237(Q117E) is solely responsible for enhanced adherence to host cells. Paradoxically, double mutants, but not TC0237(Q117E) single mutants, display severely attenuated in vivo pathogenicity. These findings implicate TC0237 and TC0668 as novel genetic factors involved in chlamydial attachment and pathogenicity, respectively, and show that serial passage under selection pressure remains an effective tool for studying Chlamydia pathogenicity.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25712926      PMCID: PMC4399068          DOI: 10.1128/IAI.03158-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  Identification of Chlamydia trachomatis outer membrane complex proteins by differential proteomics.

Authors:  Xiaoyun Liu; Mary Afrane; David E Clemmer; Guangming Zhong; David E Nelson
Journal:  J Bacteriol       Date:  2010-03-26       Impact factor: 3.490

2.  Infectivity acts as in vivo selection for maintenance of the chlamydial cryptic plasmid.

Authors:  Marsha Russell; Toni Darville; Kumar Chandra-Kuntal; Bennett Smith; Charles W Andrews; Catherine M O'Connell
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum.

Authors:  Anita A Shah; Justin H Schripsema; Mohammad T Imtiaz; Ira M Sigar; John Kasimos; Peter G Matos; Sandra Inouye; Kyle H Ramsey
Journal:  Sex Transm Dis       Date:  2005-01       Impact factor: 2.830

4.  The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells.

Authors:  Zhongyu Li; Ding Chen; Youmin Zhong; Shiping Wang; Guangming Zhong
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

Review 5.  Chlamydia vaccine candidates and tools for chlamydial antigen discovery.

Authors:  Daniel D Rockey; Jie Wang; Lei Lei; Guangming Zhong
Journal:  Expert Rev Vaccines       Date:  2009-10       Impact factor: 5.217

6.  Generation of targeted Chlamydia trachomatis null mutants.

Authors:  Laszlo Kari; Morgan M Goheen; Linnell B Randall; Lacey D Taylor; John H Carlson; William M Whitmire; Dezso Virok; Krithika Rajaram; Valeria Endresz; Grant McClarty; David E Nelson; Harlan D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

7.  Chlamydia psittaci genetic variants differ in virulence by modulation of host immunity.

Authors:  Isao Miyairi; Jonathan D Laxton; Xiaofei Wang; Caroline A Obert; Venkat R R Arva Tatireddigari; Nico van Rooijen; Thomas P Hatch; Gerald I Byrne
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

8.  Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen.

Authors:  Deborah D Crane; John H Carlson; Elizabeth R Fischer; Patrik Bavoil; Ru-ching Hsia; Chun Tan; Cho-chou Kuo; Harlan D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

9.  Intracellular interleukin-1alpha mediates interleukin-8 production induced by Chlamydia trachomatis infection via a mechanism independent of type I interleukin-1 receptor.

Authors:  Wen Cheng; Pooja Shivshankar; Youmin Zhong; Ding Chen; Zhongyu Li; Guangming Zhong
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

10.  Induction of protective immunity against Chlamydia muridarum intravaginal infection with a chlamydial glycogen phosphorylase.

Authors:  Zhihong Li; Chunxue Lu; Bo Peng; Hao Zeng; Zhiguan Zhou; Yimou Wu; Guangming Zhong
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

View more
  32 in total

1.  Intrauterine infection with plasmid-free Chlamydia muridarum reveals a critical role of the plasmid in chlamydial ascension and establishes a model for evaluating plasmid-independent pathogenicity.

Authors:  Jianlin Chen; Zhangsheng Yang; Xin Sun; Lingli Tang; Yiling Ding; Min Xue; Zhiguang Zhou; Joel Baseman; Guangming Zhong
Journal:  Infect Immun       Date:  2015-04-13       Impact factor: 3.441

2.  Gastrointestinal Coinfection Promotes Chlamydial Pathogenicity in the Genital Tract.

Authors:  Qi Tian; Zengzi Zhou; Luying Wang; Al-Mutassim Hani Abu-Khdeir; Zhi Huo; Xin Sun; Nu Zhang; Robert Schenken; Yufeng Wang; Min Xue; Guangming Zhong
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

3.  The Cryptic Plasmid Improves Chlamydia Fitness in Different Regions of the Gastrointestinal Tract.

Authors:  Jingyue Ma; Conghui He; Zhi Huo; Ying Xu; Bernard Arulanandam; Quanzhong Liu; Guangming Zhong
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

4.  Intravenous Inoculation with Chlamydia muridarum Leads to a Long-Lasting Infection Restricted to the Gastrointestinal Tract.

Authors:  Jin Dai; Tianyuan Zhang; Luying Wang; Lili Shao; Cuiming Zhu; Yuyang Zhang; Courtney Failor; Robert Schenken; Joel Baseman; Cheng He; Guangming Zhong
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

5.  Nonpathogenic Colonization with Chlamydia in the Gastrointestinal Tract as Oral Vaccination for Inducing Transmucosal Protection.

Authors:  Luying Wang; Cuiming Zhu; Tianyuan Zhang; Qi Tian; Nu Zhang; Sandra Morrison; Richard Morrison; Min Xue; Guangming Zhong
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

6.  MicroRNAs Modulate Pathogenesis Resulting from Chlamydial Infection in Mice.

Authors:  Laxmi Yeruva; Dakota L Pouncey; Michael R Eledge; Sudeepa Bhattacharya; Chunqiao Luo; Erin W Weatherford; David M Ojcius; Roger G Rank
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

7.  Chlamydia trachomatis virulence factor CT135 is stable in vivo but highly polymorphic in vitro.

Authors:  Christine Bonner; Harlan D Caldwell; John H Carlson; Morag R Graham; Laszlo Kari; Gail L Sturdevant; Shaun Tyler; Adrian Zetner; Grant McClarty
Journal:  Pathog Dis       Date:  2015-06-24       Impact factor: 3.166

8.  IL-6-mediated signaling pathways limit Chlamydia muridarum infection and exacerbate its pathogenicity in the mouse genital tract.

Authors:  Xin Sun; Qi Tian; Luying Wang; Min Xue; Guangming Zhong
Journal:  Microbes Infect       Date:  2017-08-31       Impact factor: 2.700

9.  Effects of Immunomodulatory Drug Fingolimod (FTY720) on Chlamydia Dissemination and Pathogenesis.

Authors:  Zengzi Zhou; Lingxiang Xie; Luying Wang; Min Xue; Dabao Xu; Guangming Zhong
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

10.  The Chromosome-Encoded Hypothetical Protein TC0668 Is an Upper Genital Tract Pathogenicity Factor of Chlamydia muridarum.

Authors:  Turner Allen Conrad; Siqi Gong; Zhangsheng Yang; Patrick Matulich; Jonathon Keck; Noah Beltrami; Chaoqun Chen; Zhou Zhou; Jin Dai; Guangming Zhong
Journal:  Infect Immun       Date:  2015-11-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.